Staurosporine

Staurosporine

SCHEMBL21312855

CNC1C[C@@H]2O[C@](C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCQ Q04759 15/20 1.00
PRKD3 O94806 10/20 1.00
PRKCG P05129 10/20 1.00
PRKCZ Q05513 10/20 1.00
PRKCD Q05655 10/20 1.00
PRKCB P05771 9/20 1.00
PRKCA P17252 9/20 1.00
PRKCH P24723 9/20 1.00
PRKCI P41743 9/20 1.00
PRKCE Q02156 9/20 1.00
PRKD1 Q15139 9/20 1.00
ROCK2 O75116 7/20 1.00
EGFR P00533 7/20 1.00
PRKACA P17612 7/20 1.00
PRKACG P22612 6/20 1.00
PRKACB P22694 6/20 1.00
SRC P12931 4/20 1.00
CHEK1 O14757 3/20 1.00
MAPK1 P28482 3/20 1.00
KDR P35968 3/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Staurosporine SCHEMBL12245439 1.00 PRKCQ (1.00) PRKCQPRKD3PRKCGPRKCZPRKCD
Staurosporine SCHEMBL8157 1.00 PRKCQ (1.00) PRKCQPRKD3PRKCGPRKCZPRKCD
Staurosporine SCHEMBL8156 1.00 PRKCQ (1.00) PRKCQPRKD3PRKCGPRKCZPRKCD
Staurosporine SCHEMBL14264595 1.00 PRKCQ (1.00) PRKCQPRKD3PRKCGPRKCZPRKCD
Staurosporine SCHEMBL23768489 1.00 PRKCQ (1.00) PRKCQPRKD3PRKCGPRKCZPRKCD
Staurosporine SCHEMBL13659665 1.00 PRKCQ (1.00) PRKCQPRKD3PRKCGPRKCZPRKCD
Staurosporine SCHEMBL23793206 1.00 PRKCQ (1.00) PRKCQPRKD3PRKCGPRKCZPRKCD
Staurosporine SCHEMBL17397398 1.00 PRKCQ (1.00) PRKCQPRKD3PRKCGPRKCZPRKCD
SCHEMBL24393902 1.00 PRKCQ (1.00) PRKCQPRKD3PRKCGPRKCZPRKCD
Staurosporine SCHEMBL14554228 1.00 PRKCQ (1.00) PRKCQPRKD3PRKCGPRKCZPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200223803-A1 Compositions and Methods for Treating Toxoplasmosis, Cryptosporidiosis, and Other Apicomplexan Protozoan Related Diseases UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION 2020-07-16 US disclosed
WO-2019163943-A1 MEDICINAL COMPOSITION 公益財団法人川崎市産業振興財団 2019-08-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200223803-A1 Compositions and Methods for Treating Toxoplasmosis, Cryptosporidiosis, and Other Apicomplexan Protozoan Related Diseases PNCK, TXK, CILK1 PRKCQ 194/4885PRKD3 58/4885PRKCG 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.